Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Loh

Showing results (211-220 of 479) with videos related to

Pageof 48
Sort By:
The Journal of Biological Chemistry|January 11, 2018
The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritisYi Tian Ting, Jan Petersen, Sri H Ramarathinam, et al.
Blood Advances|June 25, 2026
Minimal Residual Disease by High-Throughput Sequencing in Standard Risk-Favorable Pediatric B-Lymphoblastic LeukemiaCarol Fries, Lingyun Ji, Meenakshi Devidas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2014
Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGHDavid Wu, Ryan O Emerson, Anna Sherwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium studyRichard H Ko, Lingyun Ji, Phillip Barnette, et al.
Biomed Research International|January 13, 2015
Risk factors for hospital and long-term mortality of critically ill elderly patients admitted to an intensive care unitA Mukhopadhyay, B C Tai, K C See, et al.
Cancer Cell|October 7, 2008
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlatesNikesh Kotecha, Nikki J Flores, Jonathan M Irish, et al.
Blood|September 15, 2022
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
Blood Advances|May 2, 2022
CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemiaAstrid Wintering, Kenichi Ishiyama, Stanley Tamaki, et al.
Pediatric Blood & Cancer|September 13, 2023
Hemophagocytic lymphohistiocytosis and clonally related T-cell malignancies in a pediatric patientLauren K Meyer, Ingold Huang, Benjamin J Huang, et al.
Genome Biology|April 4, 2023
NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organizationSonali Narang, Nikki A Evensen, Jason Saliba, et al.
Pageof 48

Showing results (211-220 of 479) with videos related to

Sort By:
Pageof 48
The Journal of Biological Chemistry|January 11, 2018
The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritisYi Tian Ting, Jan Petersen, Sri H Ramarathinam, et al.
Blood Advances|June 25, 2026
Minimal Residual Disease by High-Throughput Sequencing in Standard Risk-Favorable Pediatric B-Lymphoblastic LeukemiaCarol Fries, Lingyun Ji, Meenakshi Devidas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2014
Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGHDavid Wu, Ryan O Emerson, Anna Sherwood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium studyRichard H Ko, Lingyun Ji, Phillip Barnette, et al.
Biomed Research International|January 13, 2015
Risk factors for hospital and long-term mortality of critically ill elderly patients admitted to an intensive care unitA Mukhopadhyay, B C Tai, K C See, et al.
Cancer Cell|October 7, 2008
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlatesNikesh Kotecha, Nikki J Flores, Jonathan M Irish, et al.
Blood|September 15, 2022
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.
Blood Advances|May 2, 2022
CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemiaAstrid Wintering, Kenichi Ishiyama, Stanley Tamaki, et al.
Pediatric Blood & Cancer|September 13, 2023
Hemophagocytic lymphohistiocytosis and clonally related T-cell malignancies in a pediatric patientLauren K Meyer, Ingold Huang, Benjamin J Huang, et al.
Genome Biology|April 4, 2023
NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organizationSonali Narang, Nikki A Evensen, Jason Saliba, et al.
Pageof 48